The estimated Net Worth of John R Beaver is at least $478 mil dollars as of 30 November 2021. Mr. Beaver owns over 70,000 units of Biolase Inc stock worth over $31,077 and over the last 7 years he sold BIOL stock worth over $0. In addition, he makes $446,563 as Chief Financial Officer e Executive Vice President at Biolase Inc.
Sign up
Mr. Beaver BIOL stock SEC Form 4 insiders trading
John has made over 5 trades of the Biolase Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 70,000 units of BIOL stock worth $31,500 on 30 November 2021.
The largest trade he's ever made was buying 70,000 units of Biolase Inc stock on 30 November 2021 worth over $31,500. On average, John trades about 9,000 units every 63 days since 2017. As of 30 November 2021 he still owns at least 621,530 units of Biolase Inc stock.
You can see the complete history of Mr. Beaver stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Beaver biography
John R. Beaver serves as Chief Financial Officer, Executive Vice President of the Company. He was named Senior Vice President and Chief Financial Officer in October 2017 and was promoted to Executive Vice President and Chief Financial Officer in August 2018. Prior to joining the Company, Mr. Beaver served as the Chief Financial Officer of Silicor Materials, Inc., a global leader in the production of solar silicon, from 2009 to 2013 and 2015 to 2017. Mr. Beaver also served on the Board of Directors of Silicor Materials, Inc. from 2013 to 2015. From 2013 to 2015, Mr. Beaver was Chief Financial Officer for Modumetal, Inc., a nano-laminated alloy company focused on oil and gas applications. Prior to 2009, Mr. Beaver was Senior Vice President – Finance and Chief Financial Officer at Sterling Chemicals, a mid-sized public commodity chemical manufacturer. Mr. Beaver holds a Bachelor of Business Administration in Accounting from the University of Texas at Austin and is a Certified Public Accountant.
What is the salary of John Beaver?
As the Chief Financial Officer e Executive Vice President of Biolase Inc, the total compensation of John Beaver at Biolase Inc is $446,563. There are 1 executives at Biolase Inc getting paid more, with Todd Norbe having the highest compensation of $592,590.
How old is John Beaver?
John Beaver is 58, he's been the Chief Financial Officer e Executive Vice President of Biolase Inc since 2018. There are 7 older and 6 younger executives at Biolase Inc. The oldest executive at Biolase Inc is Richard R. Whipp, 69, who is the VP of Operations.
What's John Beaver's mailing address?
John's mailing address filed with the SEC is 27042 TOWNE CENTRE DRIVE, SUITE 270, FOOTHILL RANCH, CA, 92610.
Insiders trading at Biolase Inc
Over the last 12 years, insiders at Biolase Inc have traded over $9,258,543 worth of Biolase Inc stock and bought 25,366,011 units worth $28,515,794 . The most active insiders traders include Jack W Schuler, Larry Noracle Partners Lp O..., eLarry N Feinberg. On average, Biolase Inc executives and independent directors trade stock every 57 days with the average trade being worth of $31,910. The most recent stock trade was executed by Jonathan T Md Lord on 7 December 2022, trading 3,537 units of BIOL stock currently worth $2,653.
What does Biolase Inc do?
biolase, inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. biolase’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. biolase is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.
What does Biolase Inc's logo look like?
Complete history of Mr. Beaver stock trades at Biolase Inc
Biolase Inc executives and stock owners
Biolase Inc executives and other stock owners filed with the SEC include:
-
Todd Norbe,
President, Chief Executive Officer, Director -
John Beaver,
Chief Financial Officer, Executive Vice President -
John R. Beaver,
Pres, CEO & Director -
Jonathan Lord,
Independent Chairman of the Board -
Michael Polyviou,
IR Contact Officer -
Elaine Wagner,
Independent Director -
Garrett Sato,
Independent Director -
Jess Roper,
Independent Director -
Richard Lanman,
Independent Director -
Michael DiTolla,
Independent Director -
Richard Whipp,
Vice President - Operations -
Richard R. Whipp,
VP of Operations -
Jennifer Bright,
VP of Fin. -
David Rodriguez,
Director of Education & Events -
Brendan O'Connell,
VP of Fin. and Corp. Controller -
Michael C. Carroll,
Corp. Sec. -
Holger Arens,
VP & MD of Europe, the Middle East & Africa -
Dr. Samuel B. Low,
Chief Dental Officer and VP of Dental & Clinical Affairs -
Matthew Wilson,
VP of HR -
Daniel Merkin,
National Sales Director -
Larry Noracle Partners Lp O...,
-
David C Dreyer,
SVP / Chief Financial Officer -
Jack W Jack W. Schuler Livi...,
-
Mark Joseph Nelson,
SVP & Chief Financial Officer -
Paul N Clark,
Director -
James R Talevich,
Director -
Frederic H Moll,
Director -
Harold C Jr. Flynn,
President and CEO -
Jack W Schuler,
-
Larry Noracle Partners Lp O...,
-
Carol Gomez Dds Summerhays,
Director -
Martha J. Dds, Ph D Somerman,
Director -
Larry Noracle Partners Lp F...,
-
Larry N Feinberg,
10% owner -
Frederick D. Furry,
Chief Financial Officer -
Jeffrey M Nugent,
Acting Chief Executive Officer -
Samuel Bernard Low,
Director -
Erin S. Enright,
Director -
Alexander K. Arrow,
President and COO -
Norman J. Nemoy,
Director -
Gregory Lichtwardt,
Director -
Federico Pignatelli,
Chairman and CEO -
Kenneth P. Yale,
Director -
Kathleen T O Loughlin,
Director -
Steven Sandor,
Chief Operating Officer -
Jennifer Bright,
Chief Financial Officer -
Education Foundation Schuler,